A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain

Yusuke Kakizoe, Shinji Nakaoka, Catherine A.A. Beauchemin, Satoru Morita, Hiromi Mori, Tatsuhiko Igarashi, Kazuyuki Aihara, Tomoyuki Miura, Shingo Iwami

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The time elapsed between successful cell infection and the start of virus production is called the eclipse phase. Its duration is specific to each virus strain and, along with an effective virus production rate, plays a key role in infection kinetics. How the eclipse phase varies amongst cells infected with the same virus strain and therefore how best to mathematically represent its duration is not clear. Most mathematical models either neglect this phase or assume it is exponentially distributed, such that at least some if not all cells can produce virus immediately upon infection. Biologically, this is unrealistic (one must allow for the translation, transcription, export, etc. to take place), but could be appropriate if the duration of the eclipse phase is negligible on the time-scale of the infection. If it is not, however, ignoring this delay affects the accuracy of the mathematical model, its parameter estimates, and predictions. Here, we introduce a new approach, consisting in a carefully designed experiment and simple analytical expressions, to determine the duration and distribution of the eclipse phase in vitro. We find that the eclipse phase of SHIV-KS661 lasts on average one day and is consistent with an Erlang distribution.

Original languageEnglish
Article number10371
JournalScientific reports
Volume5
DOIs
Publication statusPublished - May 21 2015

Fingerprint

Viruses
Infection
Theoretical Models
Virus Diseases
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • General

Cite this

A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain. / Kakizoe, Yusuke; Nakaoka, Shinji; Beauchemin, Catherine A.A.; Morita, Satoru; Mori, Hiromi; Igarashi, Tatsuhiko; Aihara, Kazuyuki; Miura, Tomoyuki; Iwami, Shingo.

In: Scientific reports, Vol. 5, 10371, 21.05.2015.

Research output: Contribution to journalArticle

Kakizoe, Y, Nakaoka, S, Beauchemin, CAA, Morita, S, Mori, H, Igarashi, T, Aihara, K, Miura, T & Iwami, S 2015, 'A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain', Scientific reports, vol. 5, 10371. https://doi.org/10.1038/srep10371
Kakizoe, Yusuke ; Nakaoka, Shinji ; Beauchemin, Catherine A.A. ; Morita, Satoru ; Mori, Hiromi ; Igarashi, Tatsuhiko ; Aihara, Kazuyuki ; Miura, Tomoyuki ; Iwami, Shingo. / A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain. In: Scientific reports. 2015 ; Vol. 5.
@article{2f5fd35e6e0b40d7a0b9dc9b78db1338,
title = "A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain",
abstract = "The time elapsed between successful cell infection and the start of virus production is called the eclipse phase. Its duration is specific to each virus strain and, along with an effective virus production rate, plays a key role in infection kinetics. How the eclipse phase varies amongst cells infected with the same virus strain and therefore how best to mathematically represent its duration is not clear. Most mathematical models either neglect this phase or assume it is exponentially distributed, such that at least some if not all cells can produce virus immediately upon infection. Biologically, this is unrealistic (one must allow for the translation, transcription, export, etc. to take place), but could be appropriate if the duration of the eclipse phase is negligible on the time-scale of the infection. If it is not, however, ignoring this delay affects the accuracy of the mathematical model, its parameter estimates, and predictions. Here, we introduce a new approach, consisting in a carefully designed experiment and simple analytical expressions, to determine the duration and distribution of the eclipse phase in vitro. We find that the eclipse phase of SHIV-KS661 lasts on average one day and is consistent with an Erlang distribution.",
author = "Yusuke Kakizoe and Shinji Nakaoka and Beauchemin, {Catherine A.A.} and Satoru Morita and Hiromi Mori and Tatsuhiko Igarashi and Kazuyuki Aihara and Tomoyuki Miura and Shingo Iwami",
year = "2015",
month = "5",
day = "21",
doi = "10.1038/srep10371",
language = "English",
volume = "5",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain

AU - Kakizoe, Yusuke

AU - Nakaoka, Shinji

AU - Beauchemin, Catherine A.A.

AU - Morita, Satoru

AU - Mori, Hiromi

AU - Igarashi, Tatsuhiko

AU - Aihara, Kazuyuki

AU - Miura, Tomoyuki

AU - Iwami, Shingo

PY - 2015/5/21

Y1 - 2015/5/21

N2 - The time elapsed between successful cell infection and the start of virus production is called the eclipse phase. Its duration is specific to each virus strain and, along with an effective virus production rate, plays a key role in infection kinetics. How the eclipse phase varies amongst cells infected with the same virus strain and therefore how best to mathematically represent its duration is not clear. Most mathematical models either neglect this phase or assume it is exponentially distributed, such that at least some if not all cells can produce virus immediately upon infection. Biologically, this is unrealistic (one must allow for the translation, transcription, export, etc. to take place), but could be appropriate if the duration of the eclipse phase is negligible on the time-scale of the infection. If it is not, however, ignoring this delay affects the accuracy of the mathematical model, its parameter estimates, and predictions. Here, we introduce a new approach, consisting in a carefully designed experiment and simple analytical expressions, to determine the duration and distribution of the eclipse phase in vitro. We find that the eclipse phase of SHIV-KS661 lasts on average one day and is consistent with an Erlang distribution.

AB - The time elapsed between successful cell infection and the start of virus production is called the eclipse phase. Its duration is specific to each virus strain and, along with an effective virus production rate, plays a key role in infection kinetics. How the eclipse phase varies amongst cells infected with the same virus strain and therefore how best to mathematically represent its duration is not clear. Most mathematical models either neglect this phase or assume it is exponentially distributed, such that at least some if not all cells can produce virus immediately upon infection. Biologically, this is unrealistic (one must allow for the translation, transcription, export, etc. to take place), but could be appropriate if the duration of the eclipse phase is negligible on the time-scale of the infection. If it is not, however, ignoring this delay affects the accuracy of the mathematical model, its parameter estimates, and predictions. Here, we introduce a new approach, consisting in a carefully designed experiment and simple analytical expressions, to determine the duration and distribution of the eclipse phase in vitro. We find that the eclipse phase of SHIV-KS661 lasts on average one day and is consistent with an Erlang distribution.

UR - http://www.scopus.com/inward/record.url?scp=84930216589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930216589&partnerID=8YFLogxK

U2 - 10.1038/srep10371

DO - 10.1038/srep10371

M3 - Article

C2 - 25996439

AN - SCOPUS:84930216589

VL - 5

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 10371

ER -